Concepedia

Vinay K. Holenarsipur

VK

11

Publications

622

Citations

11

H-Index

2015

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Biocon (India)

Bristol-Myers Squibb (India)

Syngene International (India)

Bristol-Myers Squibb (Germany)

Vinay K. Holenarsipur is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, pharmacotherapy, and medicine.

ORCID

Top concepts

Publications per year

2015–2022

11

Publications

11

Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition

Yurong Lai, Sandhya Mandlekar, Hong Shen et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 165 citations

Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain

Walter A. Kostich, Brian D. Hamman, S. Naidu et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 118 citations · Full text

Comparative Evaluation of Plasma Bile Acids, Dehydroepiandrosterone Sulfate, Hexadecanedioate, and Tetradecanedioate with Coproporphyrins I and III as Markers of OATP Inhibition in Healthy Subjects

Hong Shen, Weiqi Chen, Dieter M. Drexler et al. · Drug Metabolism and Disposition · 2017 · 81 citations

Evidence for the Validity of Pyridoxic Acid (PDA) as a Plasma-Based Endogenous Probe for OAT1 and OAT3 Function in Healthy Subjects

Hong Shen, Vinay K. Holenarsipur, T. Thanga Mariappan et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 57 citations · Full text

Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery

Michael M. Morgen, Ajay Saxena, Xueqing Chen et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 54 citations · Full text

, , +18

Rows per page

1–5 of 11